Mirum Pharmaceuticals, Inc. — Form 8-K
Filed September 28, 2026 · analyzed by the 8-K Agent
8-K
— Neutral
significance 8/100
What the filing says
Mirum Pharmaceuticals filed an 8-K on September 28, 2026 reporting period September 25, 2026. The filing discloses Item 8.01 (Other Events) but the specific content of that event is not provided in the document metadata or header information available. No dollar amounts, counterparties, percentages, share counts, or concrete business changes are stated in the filing excerpt.
Why this rating
Item 8.01 is catch-all disclosure category; substance unknown from metadata alone. Cannot assess materiality without actual event details.
Extracted items
See more from September 28, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.